Abstract:During the first outbreak of severe acute respiratory syndrome (SARS) in early 2003, almost 8500 people worldwide were diagnosed with the disease, and approximately 800 died of it. The epidemic was contained by July, 2003, but since then, the disease has re-emerged in the Guangdong province in Southern China around the turn of the year 2003, although the number of cases was very limited this time. In addition, there were two cases of SARS caused by improper sample handling in research laboratories in Singapore and Taiwan. A “mini-outbreak” originated from several independent laboratory infections at a research laboratory in Beijing in March and April, 2004, and led to infection chains encompassing three generations.This time, China escaped another epidemic since fortunately, the number of diseased people was limited to nine, although there was one fatality. In any case, these isolated mini-outbreaks remind us of the global threat that SARS still represents. In late March, 2003, a new coronavirus, SARS-CoV, was isolated from affected tissue of SARS patients and identified as the cause of the disease [1, 2]. Coronaviridae are RNA viruses that have been united with the families Arteriviridae and Roniviridae in the order Nidovirales. The phylogenetic relationship of these morphologically unrelated virus families is based on their similar polycistronic genome organization, common transcriptional and post-translational strategies, and a conserved array of homologous domains in the viral polyproteins [3–5]. Coronaviruses are responsible for a number of diseases of man and animals, some of which have major economical impacts, although the human coronaviruses have clearly been neglected before SARS emerged. Transmissible gastroenteritis virus (TGEV) infection is associated with severe and often fatal diarrhoea in young pigs [6, 7]. The human coronaviruses (HCoV) 229E and OC43 are major causes Coronavirus main proteinase: target for antiviral drug therapy

A Global View of DNA-Packing Proteins Cracks the Histone Code

Casting a Wide Net to Fight Coronaviruses

Mapping Core Communication Networks in Bacteria

The Molting Worm Sheds Its Genetic Secrets

Complex Cells in the Brain's Vision Center Tune in to Natural Scenes

Comparing Gene Trees and Genome Trees: A Cobweb of Life?

Fibroblast Culture Cells Keep Track of Circadian Rhythms

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design.

A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019‐nCoV)

Synthetic Peptides Outside the Spike Protein Heptad Repeat Regions As Potent Inhibitors of Sars-Associated Coronavirus

Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core.

Mass Spectrometry Analysis of SARS-CoV-2 Nucleocapsid Protein Reveals Camouflaging Glycans and Unique Post-Translational Modifications

Characterization of the Heptad Repeat Regions, HR1 and HR2, and Design of a Fusion Core Structure Model of the Spike Protein from Severe Acute Respiratory Syndrome (SARS) Coronavirus.

Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases.

Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets.

Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy

In Vivo Structural Characterization of the SARS-CoV-2 RNA Genome Identifies Host Proteins Vulnerable to Repurposed Drugs.

Extracellular Disintegration of ViralProteins As an Innovative Strategyfor Developing Broad-SpectrumAntivirals Against Coronavirus

Drug Design Targeting the Main Protease, the Achilles Heel of Coronaviruses

Coronavirus Main Proteinase: Target for Antiviral Drug Therapy

Structural proteomics of the SARS coronavirus: a model response to emerging infectious diseases